CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Takeda Pharmaceuticals U.S.A., Inc. v. Granules Pharmaceuticals, Inc.

1:20-cv-00812

Overview

Case Number 1:20-cv-00812
Filing Date 2020-06-16
Status Terminated
Termination Date 2020-10-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Granules Pharmaceuticals, Inc. Operating Company

Represented By

4 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

James P. Barabas

Email: jbarabas@windelsmarx.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

1000 West Street, Suite 1501, Wilmington, DE 19801

Constance S. Huttner

Email: chuttner@windelsmarx.com

Plaintiff

Takeda Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

6 Attorneys Listed

Thatcher A. Rahmeier

Faegre Drinker Biddle & Reath LLP

Tel: +1 (302) 467-4211
Fax: +1 (302) 467-4201

222 Delaware Avenue, Suite 1410

Porter F. Fleming

Email: pfleming@haugpartners.com

Jonathan Herstoff

Email: jherstoff@haugpartners.com

Edgar H. Haug

Email: ehaug@haugpartners.com

Camille Y. Turner

Email: cturner@haugpartners.com

Francis DiGiovanni

Faegre Drinker Biddle & Reath LLP

Tel: +1 (302) 467-4266
Fax: +1 (302) 467-4201

222 Delaware Avenue, Suite 1410

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 8 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (8 found):
U.S. Courts: 8
U.S. District Court 2023-11-06
1:23-cv-01264

Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2020-06-24
1:20-cv-00845

Takeda Pharmaceuticals U.S.A., Inc. v. Dr. Reddy's Laboratories, Ltd.

Asserted Patent
Status: DED
U.S. District Court 2019-12-02
1:19-cv-02216

Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-10-24
1:16-cv-00987

Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-10-03
1:14-cv-01268

Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-27
1:14-cv-00268

Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-08-30
1:13-cv-01524

Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-04-04
1:12-cv-00419

Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7906519
Methods for concomitant administration of colchicine and a second active agent
Filed: 2010-08-18
Issued: 2011-03-15
Active (3.7 yrs remaining)
Expires: 2030-08-18
US7935731
Methods for concomitant administration of colchicine and macrolide antibiotics
Filed: 2010-05-25
Issued: 2011-05-03
Active (3.5 yrs remaining)
Expires: 2030-05-25
US8093298
Methods for concomitant administration of colchicine and macrolide antibiotics
Filed: 2011-05-18
Issued: 2012-01-10
Active (4.5 yrs remaining)
Expires: 2031-05-18
US7964648
Methods for concomitant administration of colchicine and a second active agent
Filed: 2010-01-15
Issued: 2011-06-21
Active (3.2 yrs remaining)
Expires: 2030-01-15
US8093297
Methods for concomitant administration of colchicine and a second active agent
Filed: 2011-04-22
Issued: 2012-01-10
Active (4.4 yrs remaining)
Expires: 2031-04-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 4 Motion to Stay 2

Key Dispositive Motions & Rulings

Motion to Stay Pending / Under Review
STIPULATION and Proposed Order to Stay the Case, by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 10/2/2020 (nms). (Entered: 10/02/2020...
Entry #15 • 2020-10-02 Document →
Motion to Stay Pending / Under Review
SO ORDERED Granting 15 Stipulation and Proposed Order to Stay the Case. Signed by Judge Richard G. Andrews on 10/2/2020. (nms) (Entered: 10/02/2020)
Entry #16 • 2020-10-02 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 14 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to November 9, 2020 (*Reset Answer Deadlines: Granules Pharmaceu...
Entry #β€” • 2020-08-19
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to November 9, 2020 - filed by Granules Pharmaceuticals, Inc.. (Ormerod, Eve) (Ent...
Entry #14 • 2020-08-18 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to September 8, 2020 - filed by Granules Pharmaceuticals, Inc.. (Belgam, Neal) (En...
Entry #13 • 2020-07-07 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 13 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to September 8, 2020 (*Reset Answer Deadlines: Granules Pharmace...
Entry #β€” • 2020-07-07

Docket Entries

(42 total)
Pleading / Complaint

MOTION for Confidential Treatment of the Complaint and Its Exhibit A - filed by Takeda Pharmaceuticals U.S.A., Inc. (sam) (Entered: 06/16/2020)

Entry #1 • 2020-06-16
1
Pleading / Complaint

DECLARATION of Thatcher A. Rahmeier in support of 1 MOTION to Confidential Treatment of the Complaint and Its Exhibit A - by Takeda Pharmaceuticals U.S.A., Inc. (sam) (Entered: 06/16/2020)

Entry #2 • 2020-06-16
1
Pleading / Complaint

[SEALED] COMPLAINT filed with Jury Demand against Granules Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2998250.) - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Exhibit A)(sam) (Entered: 06/16/2020)

Entry #3 • 2020-06-16
1
Pleading / Complaint

EXHIBITS B-L to 3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # 1 Civil Cover Sheet, # 2 Related Cases)(sam) Modified on 6/17/2020 (nms). (Entered: 06/16/2020)

Entry #4 • 2020-06-16
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519 ;7,935,731 ;8,093,298 ;7,964,648 ;8,093,297. (sam) (Entered: 06/16/2020)

Entry #5 • 2020-06-16
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc